1. 603 Covalent attachment of a TLR7/8 agonist to tumor-targeting antibodies drives potent anti-tumor efficacy by synergistically activating FcgR- and TLR- signaling and enables safe systemic administration. (9th November 2020) Authors: Ackerman, Shelley; Hartmann, Felix; Pearson, Cecelia; Gonzalez, Joseph; Ho, Po Yi; Kimmey, Samuel; Luo, Andrew; Ackerman, Benjamin; Lee, Arthur; Laura, Richard; Paik, Jason; Henning, Karla; Jackson, David; Chapin, Steven; Devens, Bruce; Dornan, David; Bendall, Sean; Engleman, Edgar; Alonso, Michael Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A360 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 603 Covalent attachment of a TLR7/8 agonist to tumor-targeting antibodies drives potent anti-tumor efficacy by synergistically activating FcgR- and TLR- signaling and enables safe systemic administration. (9th November 2020) Authors: Ackerman, Shelley; Hartmann, Felix; Pearson, Cecelia; Gonzalez, Joseph; Ho, Po Yi; Kimmey, Samuel; Luo, Andrew; Ackerman, Benjamin; Lee, Arthur; Laura, Richard; Paik, Jason; Henning, Karla; Jackson, David; Chapin, Steven; Devens, Bruce; Dornan, David; Bendall, Sean; Engleman, Edgar; Alonso, Michael Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A638 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 605 Systemically administered HER2-targeted ISACs provoke a rapid, local response that engages the innate and adaptive arms of the immune system to eradicate tumors in preclinical models. (9th November 2020) Authors: LeBlanc, Heidi; Pearson, Cecelia; Kenkel, Justin; Blum, LIsa; Ho, Po; Luo, Angela; Laura, Richard; Zhou, Matthew; Gregorio, Joshua; Luo, Andrew; Ackerman, Shelley; Safina, Brian; Dornan, David; Alonso, Michael; Kowanetz, Marcin Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A640 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 605 Systemically administered HER2-targeted ISACs provoke a rapid, local response that engages the innate and adaptive arms of the immune system to eradicate tumors in preclinical models. (9th November 2020) Authors: LeBlanc, Heidi; Pearson, Cecelia; Kenkel, Justin; Blum, LIsa; Ho, Po; Luo, Angela; Laura, Richard; Zhou, Matthew; Gregorio, Joshua; Luo, Andrew; Ackerman, Shelley; Safina, Brian; Dornan, David; Alonso, Michael; Kowanetz, Marcin Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A361 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗